Entwicklung und Validierung des Stapesplasty Outcome Test 25 (SPOT-25)

• Verfasst von: Lailach, Susen [VerfasserIn]
• Verfasst von: Baumann, Ingo [VerfasserIn]
• Verfasst von: Walter, Hannah [VerfasserIn]
• Verfasst von: Praetorius, Mark [VerfasserIn]
• Titel: Entwicklung und Validierung des Stapesplasty Outcome Test 25 (SPOT-25)
• Verf.angabe: S. Lailach, T. Schenke, I. Baumann, H. Walter, M. Praetorius, T. Beleites, T. Zahnert, M. Neudert
• E-Jahr: 2017
• Jahr: 17 July 2017
• Umfang: 8 S.
• Fussnoten: Gesehen am 25.10.2018
• Titel Quelle: Enthalten in: HNO
• Ort Quelle: Berlin : Springer, 1996
• Jahr Quelle: 2017
• Band/Heft Quelle: 65(2017), 12, Seite 973-980
• ISSN Quelle: 1433-0458
• DOI: doi:10.1007/s00106-017-0389-x
• Datenträger: Online-Ressource
• Sprache: ger
• Sach-SW: Ergebnisbewertung
• Sach-SW: Fragebogen
• Sach-SW: Gesundheitsbezogene Lebensqualität
• Sach-SW: Health-related quality of life
• Sach-SW: Otosclerosis
• Sach-SW: Otosklerose
• Sach-SW: Outcome analysis
• Sach-SW: Patient-reported Outcomes
• Sach-SW: Questionnaire
• Sach-SW: Therapiebeurteilung aus Patientensicht
• K10plus-PPN: 1582277133

Abstract

Background: Otosclerosis affects health-related quality of life (HRQOL). Until now, measurements have only been performed using audiometric data or non-validated quality of life questionnaires.ObjectiveThe objective of this study was to develop the first validated disease-specific HRQOL measuring instrument to determine HRQOL in otosclerosis. Materials and methods: After sequential analysis and item reduction of the initial Stapesplasty Outcome Test 47 (SPOT-47), the SPOT-25 was validated prospectively on 52 otosclerosis patients undergoing stapes surgery. In addition to the overall score, four subscores were defined (hearing function, tinnitus, social restrictions, mental condition). Results: The SPOT-25 showed a high internal consistency (Cronbach’s α > 0.7), allowed discrimination between otosclerosis patients and healthy subjects, and demonstrated acceptable test-retest reliability (r = 0.85). After stapes surgery, the HRQOL improved significantly. The responsiveness was high. Conclusion: The SPOT-25 is the first validated disease-specific instrument for HRQOL measurement in otosclerosis patients. It should be used routinely for quality control.